Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma.
Blood Adv
; 5(18): 3563-3567, 2021 09 28.
Article
in En
| MEDLINE
| ID: mdl-34474474
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunotherapy, Adoptive
/
Lymphoma, B-Cell
Limits:
Adult
/
Humans
Language:
En
Journal:
Blood Adv
Year:
2021
Document type:
Article
Affiliation country:
Morocco
Country of publication:
United States